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Hair Follicle Signaling Networks:
A Dermal Papilla–Centric Approach
Raul Ramos1, Christian F. Guerrero-Juarez1 and Maksim V. Plikus1
Functional testing of dermal papilla (DP) signaling inputs into hair follicle (HF)
morphogenesis and regeneration is becoming possible with the advent of new
Cre lines. Targeted deletion of the signature genes in early DP precursors has
revealed significant signaling redundancy during HF morphogenesis. Furthermore,
the DP lineage commitment program can be exploited for generating highly
inductive DP cells to be used in HF bioengineering assays.
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Novel genetic tools: dermal papilla in the
spotlight
The early availability of keratin-specific
genetic tools provided epithelial biolo-
gists nearly a two-decade head start over
those who studied mesenchymal aspects
of HF function. Indeed, careful gene
ablation and overexpression studies
have now brought our understanding
of follicular bulge stem cells to a level
that rivals that of hematopoetic stem
cells. Owing to these studies, the HF
now holds the position of a model
system for many stem cell investigators.
At the same time, classic tissue-
recombination and transplantation
experiments have revealed critical roles
for mesenchymal dermal papilla (DP) in
regulating various aspects of HF biol-
ogy, such as regenerative cycling. More-
over, recent clinical data indicate that
human scalp HFs affected by andro-
genic alopecia contain a largely intact
population of bulge stem cells and that
the primary defect is in DP signaling,
rendering it unable to support long-
lasting phases of hair growth. However,
it was not until recently that the mole-
cular identity of DP signaling input into
hair morphogenesis and growth was
revealed. New DP-specific genetic tools
now make it possible to study HF
signaling networks during development
and during adulthood.
The paper by Grisanti et al. (2013b)
in this issue is the latest in a series
of studies that use specificity of
expression of the T-box transcription
factor Tbx18 in DP precursor cells in
embryonic dermal condensates for
genetic labeling, isolation, and genetic
targeting of these precursor cells during
the early stages of HF morphogenesis.
Indeed, Tbx18-driven Cre knock-in
lines, as well as the Tbx18H2BGFP
reporter, become active at embryonic
day 14.5, coinciding with the early
event of dermal condensation during
morphogenesis of primary HFs in mice
(Clavel et al., 2012; Grisanti et al.,
2013a). This specificity of Tbx18Cre for
embryonic DP progenitors enables the
investigation of their role in signaling
networks during primary HF develo-
pment. Both constitutive and inducible
Tbx18Cre can be used for efficient
DP-specific gene ablation, such as
Sox2, as shown in Clavel et al. (2012),
and Enpp2, as shown by Grisanti et al.
(2013b).
Because Tbx18 is activated in dermal
condensations as they are being
specified by placode signals, genetic
targeting of dermal progenitors at earlier
stages can be achieved with alternative
Cre lines, such as Dermo1-Cre (Fu and
Hsu, 2013), En1-Cre (Chen et al., 2012),
Prx1-Cre (Woo et al., 2012), and
HoxB6-CreERT1 (Chen et al., 2012). In
contrast, genetic targeting of DPs in fully
formed HFs can be achieved with
Corin-Cre (Enshell-Seijffers et al., 2010).
Taken together, these Cre lines now
make it possible to study the signaling
regulation of HF development and
cycling using a DP-centric approach.
DP signature genes: which ones matter
the most?
Unique properties of DP cells, most
distinctly, their ability to induce forma-
tion of new HFs when combined with
competent epithelial cells, have long
fascinated hair researchers. Moreover,
reconstitution of new HFs from patient-
specific inductive DP and competent
epithelial cells has long been considered
a viable therapeutic strategy for restoring
hair growth. Yet, although mouse DP
cells often demonstrate impressive
inductive abilities in HF reconstitution
assays, adult and even fetal human DP
cells are less prone to induction. Thus,
protocols aimed at increasing the induc-
tive abilities of human adult DP cells
have to be developed. An alternative
strategy for obtaining highly inductive
DP cell populations could potentially be
to generate early embryonic-like DP
precursors from patient-derived iPS cells
or from patient’s adult cells, such as
dermal fibroblasts, through their direct
reprogramming. For such iPS- and
reprogramming-based HF therapeutics
to become a useful approach, much
work has to be done to understand the
basic biology of the highly specialized
DP cell lineage commitment program.
To this end, newly developed DP-spe-
cific cell sorting and Cre-targeting stra-
tegies now make it possible to establish
functionally relevant DP signature genes
and master regulators of the DP lineage
commitment program.
DP lineage can best be understood in
the context of a stereotypical cell line-
age program (Figure 1). Ontogeny of
any given cell type starts with the
commitment event, when precursor
cells choose a new fate following expo-
sure to one or several morphogenetic
cues from their microenvironment. This
leads to relatively stable gene expression
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changes mediated by distinct transcrip-
tion factors, known as lineage master
regulators. Commitment to the DP line-
age likely occurs following exposure
of embryonic skin mesenchyme to
Fgf20 produced by the epithelial placode
(Huh et al., 2013), whereas cells of early
dermal condensations can be viewed as
already committed to the DP fate. Follow-
ing commitment, progenitors under-
go lineage maturation, during which
they progressively acquire terminally
differentiated characteristics. Depending
on the cell type, lineage maturation can
be accompanied by additional rounds of
fate selection between alternative sub-
lineages, such as in the case of hemato-
poietic cells. Lineage maturation also can
proceed without further divergent choices,
such as in the case of skeletal muscle
or cartilage. Maturation of committed DP
precursors gives rise to DP and dermal
sheath cell types of an adult HF (Grisanti
et al., 2013a).
The differentiated state of adult DP
cells is dependent on continuous signal-
ing feedback from the surrounding
microenvironment of the HF, most dis-
tinctly, from epithelial matrix cells dur-
ing anagen phase and from secondary
hair germ and bulge stem cells during
telogen phase. As the signaling input
differs greatly between anagen and telo-
gen phases of the hair-growth cycle, DP
transitions between functionally distinct
active (anagen) and quiescent (telogen)
states (Rendl et al., 2005; Greco et al.,
2009). Rendl et al. (2008) and others
have shown that DP cells quickly lose
their differentiated properties when
taken out of the context of their
HF microenvironment. Indeed, freshly
sorted DP cells lose all but a handful of
genes from their original in vivo expres-
sion signature after only one passage
in vitro. This coincides with the loss of
their inductive abilities in HF reconsti-
tution assays (Rendl et al., 2008). Thus,
comparative expression profiling of
freshly isolated versus cultured DP cells
can yield valuable insight into the
regulatory aspects of the DP lineage.
The core identity characteristics of any
given cell lineage become established
during their initial commitment, and they
include one or several master transcrip-
tion factors acting via the so-called super-
enhancers to activate expression of their
downstream target genes. These genes, in
turn, endow cells with their baseline
lineage identity characteristics stably
and highly (Figure 1). Activation of such
master transcription factors can be
exploited for instructing iPS cells or
adult-differentiated cells to undergo spe-
cification toward a new desirable cell
type via their redifferentiation or direct
reprogramming, respectively. Indeed, iPS
cell redifferentiation and direct repro-
gramming protocols have now been
established for various cell lineages and,
in some cases, such as for insulin-produ-
cing pancreatic b-cells, such protocols
have been optimized for high efficiency.
Similar approaches for achieving induc-
tive DP precursors are, thus, highly desir-
able from the clinical point of view.
Transcriptional regulation via super-
enhancers is inherently stable, and mas-
ter transcription factors autoregulate
themselves via positive feedback loops.
Therefore, they should resist downregu-
lation under stress conditions, such as
in vitro cell culture. Indeed, although
some DP signature transcription factors,
such as Alx3, Alx4, and Hey1 are down-
regulated rapidly in culture, others, such
as homeobox protein Sox2 and zinc-
finger protein Snai2, remain expressed
at high levels (Rendl et al., 2008). On
the basis of these and other characteris-
tics, Sox2 was regarded as a putative
master regulator of the DP lineage in all
but zigzag HFs (in the latter, HF-type
Sox2 is distinctly absent from DP).
Recently, Clavel et al. (2012) were
able to test the functional importance
of Sox2 in this context by ablating its
expression genetically in early dermal
condensates. Surprisingly, despite
specific and efficient Sox2 ablation in
newly committed DP precursors, HF
morphogenesis proceeded largely undis-
turbed and Sox2-deficient precursors
matured into adult, albeit dysfunc-
tional, DP cells. These data reveal
either a redundancy in Sox2 function
during DP lineage specification or a
leading role in this process for an, as of
yet unidentified, transcription factor(s).
A recent study by Woo et al. (2012)
indicates that other transcription factors,
such as Sox18, can potentially compen-
sate for Sox2 function. Sox2, however,
has an additional, non-compensated
role in DP cells. Comprehensive ana-
lysis of Tbx18Cre;Sox2 / mutant HFs
has revealed its essential role in fine-
tuning bone morphogenetic protein sig-
naling activity in the overlying matrix,
where it acts to regulate upward migra-
tion of hair shaft progenitors (Clavel
et al., 2012).
In an effort to evaluate the functional
significance of other key DP signature
genes, Grisanti et al. (2013b) of this issue
report on the Tbx18Cre-mediated ablation
of Enpp2 (aka Autotaxin), an enzyme
participating in the production of
lysophosphatidic acid (LPA) and the
highest differentially expressed gene in
adult DPs compared with adult dermal
fibroblasts. LPA signals via several LPA
receptors, which, in HFs, have complex
and overlapping distribution patterns
spanning both epithelial and mesen-
chymal compartments. Following care-
ful examination, the authors showed that
Enpp2 is dispensable for HF morpho-
genesis and DP lineage maturation.
Although surprising on the surface, this
result echoes the effect of Sox2 ablation
(Clavel et al., 2012), and it speaks in
favor of redundancy at the level of highly
enriched DP signaling regulators. Indeed,
data by Grisanti et al. (2013b) suggest
that Enpp2 deletion can be compensated
functionally by lipase member H, a
phospholipase that can generate LPA
via a pathway alternative to Enpp2.
Importantly, studies by Clavel et al.
(2012) and Grisanti et al. (2013b)
Clinical Implications
 Activating DP transcriptional master regulators will enable the production
of patient-specific DP cells from induced pluripotent stem (iPS) cells.
 Strategies can be devised for using iPS-derived DP cells to bioengineer
new human HFs that are resistant to androgenic alopecia.
 Candidate regulators of DP inductive properties can now be tested in
gene ablation studies using DP-specific Cre lines.
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of this issue map out a novel genetic
strategy for systematically examining
the functional significance of DP
signature genes both in its own lineage
specification and, more broadly, in HF
morphogenesis. Future gene ablation
studies using DP-specific Cre lines will
undoubtedly reveal the molecular
identity of DP lineage master regu-
lators. An in-depth understanding of
the DP lineage commitment program
will help devise protocols for achieving
highly inductive patient-specific DP
cells and improve prospects for HF
bioengineering therapies for alopecia.
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Figure 1. Dermal papilla (DP) lineage program. DP cells form during embryonic HF development from initially uncommitted mesenchymal precursors. Formation
of the DP lineage likely follows a stereotypical cell lineage program, which starts with the commitment event. Although DP lineage commitment is likely
associated with stable gene expression changes, signaling characteristics of differentiated DP cells are unstable and can be rapidly lost in culture. Signaling
networks of DP lineage can now be studied using several stage-specific Cre lines. Mechanisms of the DP lineage commitment and differentiation can be exploited
for developing optimized HF bioengineering therapies for alopecia (listed at the top). iPS, induced pluripotent stem; Shh, Sonic hedgehog.
Psoriasis and Cardiovascular Disease:
Where Is the Risk?
Catriona M. Maybury1, Jonathan N. Barker1 and Catherine H. Smith1
In this issue, Dowlatshahi et al. publish results from their population-based study
in Rotterdam showing that, despite an increase in body mass index and smoking,
individuals with psoriasis have no increased risk of incident cardiovascular disease.
These results should be interpreted with caution: the study included relatively
small numbers of patients with psoriasis, most of whom had mild disease.
Journal of Investigative Dermatology (2013) 133, 2308–2311. doi:10.1038/jid.2013.207
Background to psoriasis and
cardiovascular risk
Psoriasis is now recognized as a chronic
inflammatory skin disease that is more
than ‘‘skin deep.’’ The reported associa-
tion between psoriasis and cardiovas-
cular disease (CVD) has attracted
considerable interest in the last decade
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